Current and Future Challenges of Innovative Oncology Drugs Development
Noordwijk aan Zee, Netherlands – 8-10 February 2021
The Cancer Drug Development Forum (CDDF) Spring conference 2021 is a unique forum that convenes every year and gathers the leaders in the world of innovative cancer therapy development, including medical researchers, pharmaceutical industry representatives, regulatory authority representatives and patient advocacy groups. It is the successor of the former CDDF Alpine Conference and the 12th edition takes place from 8 to 10 February 2021, in the Netherlands.
This multi-stakeholder, interactive meeting offers plenary lectures with moderated discussions, including case studies and networking opportunities. The programme focuses on the latest and future challenges of Innovative oncology drugs development with a special emphasis on patient access, cancer drug development in a global setting, advances in imaging and regulatory guidance on oncology drug development.
- Jaap Verweij (CDDF Board, NL)
- Irmela Radtke (Roche, CH)
- Marnix Bosch (Northwest Biotherapeutics, UK)
- Ralf Herold (European Medicines Agency, NL)
- Paul Stockman (AstraZeneca, UK)
- Judith Taylor (Thyroid Cancer Alliance, Member of WECAN, UK)
The target is a multidisciplinary audience of academia representatives, EU and US regulatory bodies (EMA, FDA, National Agencies), pharmaceutical Industry, HTAs and patient advocates.
- View the draft programme HERE
Registration will be open soon.